PHILADELPHIA — (April 30, 2025) —The Wistar Institute, a world leader in cancer, immunology, and infectious disease research, announces the appointment of Xiaoyu (Ariel) Zhou, Ph.D., as assistant professor in the Vaccine & Immunotherapy Center.
PHILADELPHIA — (March 20, 2025) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome three new members to its Board of Trustees.
PHILADELPHIA — (Feb. 28, 2024) — The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive brain cancers reprogram immune system cells from fighting cancer to enabling further tumor gr…
In newly reported clinical trial results, The Wistar Institute and Stanford University have successfully tested an investigational drug for the treatment of Epstein-Barr Virus (EBV)-positive nasopharyngeal cancer (NPC) in humans.
PHILADELPHIA — (Nov. 26, 2024) — The Wistar Institute’s Alessandro Gardini, Ph.D., and lab have shed new light on how certain biological processes determine the development of neural cells. Their findings on a molecular “bridge” complex demonstrate…
In July 2024, Jozef Madzo, Ph.D., joined Wistar’s faculty as an assistant professor and new director of the Bioinformatics Core Facility, which provides investigators with critical data analysis support. We sat down with him to learn more about how…
In front of the 200-plus audience gathered in The Wistar Institute’s standing-room-only Sarah and Matthew Caplan Auditorium — as well as many more tuning in virtually — the 2023 Nobel Laureate in Physiology or Medicine, Katalin Karikó, Ph.D., receiv…
PHILADELPHIA — (Oct. 8, 2024) — New research from The Wistar Institute’s Salvino lab — led by professor Joseph Salvino, Ph.D. — has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that, acco…
